After more than 40 years of dedicated research, scientists have confirmed that curing HIV is no longer a theoretical possibility but a reachable goal. While only a handful of individuals have been cured to date, these rare cases prove that the virus can be eliminated from the body, offering hope to the more than 40 million people living with HIV worldwide. Researchers now agree the question is not whether a cure is possible, but how to deliver it safely and at scale.
The path to a cure involves solving several key challenges. Scientists must first identify where HIV hides in the body, specifically the HIV reservoir of latent virus that standard antiretroviral drugs cannot reach. They must then measure this reservoir accurately and either eliminate those infected cells or keep them permanently suppressed without daily medication. In 2025, a major breakthrough showed that dormant HIV could be reactivated using mRNA technology, making infected cells visible to the immune system and overcoming a critical barrier to curing the virus.
Researchers are pursuing two main types of cure. An eradication cure would remove HIV completely from the body. A functional cure, considered a more realistic near-term goal, would allow the immune system to control the virus at very low levels without daily antiretroviral therapy. For most experts, a functional cure would be a major breakthrough, enabling people to stop lifelong treatment while remaining healthy and unable to transmit the virus. Advances in gene and cell therapies, including engineered immune cells and gene editing, are opening new ways to make immune cells resistant to HIV or to target infected cells more precisely.
New Technologies and Tools Accelerate Progress
The rapid development of COVID-19 vaccines provided powerful proof that mRNA and lipid nanoparticle technologies can deliver biological instructions to the body quickly and effectively. While the same approach does not automatically cure HIV, it demonstrated the speed at which such tools can be designed and deployed. Meanwhile, artificial intelligence is helping researchers analyze more than 40 years of HIV research data, identifying patterns and therapeutic opportunities that would otherwise remain hidden. AI will not replace scientists, but it can accelerate the discovery of connections between different lines of investigation.
Looking ahead, the focus is on helping the immune system recognize and eliminate HIV-infected cells. Researchers are studying T cells, antibodies, immune exhaustion, vaccines, and engineered immune approaches to achieve long term control without lifelong treatment. Although a cure is not right around the corner, the scientific community has never been more confident. The goal now is to connect the right technologies in the right way, safely and at scale, bringing the end of AIDS within reach for millions.